H1N1 Vaccine Market - Forecast(2022 - 2027)

Report Code: HCR 0129 Report Format: PDF + Excel

H1N1 Vaccine Market Overview

H1N1 Vaccine Market size is estimated to reach $4.6 billion by 2027, growing at a CAGR of 5.1% during the forecast period 2022-2027. H1N1 is widely known as swine flu, and it is a highly transmissible infection instigated by the H1N1 influenza strain. The infection mainly spreads with the help of skin-to-skin contact, mucus particles, and spittle. The disease is of curable nature and can be prevented through vaccines. Oseltamivir phosphate, an antiviral drug is approved by the Food and Drug Administration (FDA) for the treatment of several complex influenzas. It is fabricated by using various additives like croscarmellose sodium, pregelatinized starch, and others. Such antiviral drug makes the flu less severe by bringing down the intensity of respiratory complications like fever, sore throat, cough, and runny nose. H1N1 vaccine can be administered into the body in several ways like an intradermal vaccine, intermuscular and intranasal. The intranasal vaccines also have monosodium glutamate. Nevertheless, the intramuscular delivery route is the most commonly taken into account. The H1N1 vaccine market outlook is exceptionally captivating as communicable illnesses are cruising around the world at a relentless pace. Broadening research and development activities for noel drug discoveries, and elevation in the number of people afflicted with H1N1 influenza are factors set to drive the growth of the H1N1 Vaccine Industry for the period 2022-2027.

Report Coverage

The report: “H1N1 Vaccine Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the H1N1 Vaccine Market. 

By Type: Inactivated, Conjugate, and Attenuated.
By Brand: Vaxigrip, Nasovac, Agripal, Influgen, and others.
By Administration: Subcutaneous, Intramuscular, Intranasal, and Intradermal. 
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

  • Geographically, the North America H1N1 Vaccine Market accounted for the highest revenue share in 2021. It is owing to the presence of robust medical infrastructure which allows for healthy growth. Nevertheless, Asia -Pacific is poised to dominate the market over the period 2022-2027.
  • A swell in transmissions of swine flu due to proliferating old age is said to be a preeminent driver driving the growth of the H1N1 Vaccine Market. The lack of skilled professionals in respective fields is said to reduce the market growth.
  • Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the H1N1 Vaccine Market report.

H1N1 Vaccine Market- Geography (%) for 2021.

H1N1 Vaccine Market

For More Details on This Report - Request for Sample

H1N1 Vaccine Market Segment Analysis-By Type

The H1N1 Vaccine Market based on the type can be further segmented into Inactivated, Conjugate, and Attenuated. The conjugate segment held the largest share in 2021. The growth is owing to the humungous production of conjugate vaccines around the globe. The recombinant or conjugates are known for their high effectiveness and long-term fortification. Similarly, the conjugate vaccines segment is estimated to be the fastest-growing segment with a CAGR of 6.8% over the forecast period 2022-2027. This growth is owing to a lower risk of side effects as compared to other vaccines. The conjugate vaccines are of utmost help when it comes to generating an invulnerable response against CPSs. Conjugate vaccines condense the mucosal carriage which is one of the biggest prerequisites to developing herd immunity against pathogens. Nevertheless, these vaccines' use is not only limited to curing invasive diseases. They are significant in noninvasive ailments like acute otitis. 

H1N1 Vaccine Market Segment Analysis-By Administration

The H1N1 Vaccine Market based on administration can be further segmented into Subcutaneous, Intramuscular, Intranasal, and Intradermal. The Subcutaneous and Intramuscular segments held the largest share in 2021. The growth is owing to easy and higher absorption of therapeutic drugs as compared to other modes of delivery. Also, muscles are known as an abundant source of blood which increases the pace of medication immersion. Likewise, subcutaneous injection is taken into account when drugs are administered between muscles and skin. Furthermore, the intramuscular segment is estimated to be the fastest-growing segment with a CAGR of 6.3% over the forecast period 2022-2027. This growth is owing to rising cases of discomforts associated with intradermal administration such as burning, and inflammation. Sometimes drugs injected in this way take more than 24 hours to absorb which eventually decreases the pace of patient recovery. 

H1N1 Vaccine Market Segment Analysis-By Geography 

The H1N1 Vaccine Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 34% of the overall market in 2021. The growth in this segment is owing to the factors such as the escalating prevalence of transmissible diseases with dwindling immunities of residents. On another hand, due to rich and full-fledged economies North American nation spends an innumerable amount of hard cash on research and developmental activities. The presence of leading players in the respective market is another big factor contributing to the growth of the respective market. As for the flu vaccine dashboard of the states, around 170.2 million doses have been distributed. Effectively, the flu shots cover the H1N1 strains as well.

However, the Asia-Pacific segment is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to broadening the old-age population in nations. On another hand, India and China are famous for their top-flight engineers which are helping them discover novel drugs and techniques. 

H1N1 Vaccine Market Drivers

Soaring prevalence of communicable diseases is Anticipated to Boost Product Demand. 

The prevalence of the transmissible disease is swelling day after day attributed to dwindling immunities. The smoking trends and poor ingestion habits are the prime factors behind hampered digestion power. Consequently, with a reduced capacity of the body to fight diseases, many communicable illnesses are coming to the foreground. The H1N1 was declared a pandemic by the world health organization in 2009-10 when it claimed more than 284,000 lives. Moreover, in a recent survey of 41% of households in the capital city of India more than 2-3% of cases were found positive.

Enlarging research and developmental activities are Expected to Boost Product Demand.

The surging trend of hospitalization as a big chunk of the total world population is getting older. As the old-age population is anticipated to reach 1-2 billion within a few years the health care sector has become the priority of governments around the globe. Therefore, they are allocating more funds to research and development processes. Following the 1st wave of the pandemic, the Indian government increased its healthcare spending by 137%. Moreover, healthcare spending in developed countries like the U.S. is expected to reach the 6 trillion mark by the year 2028. 

H1N1 Vaccine Market Challenges

Lack of skilled professionals along with low interest in flu is Anticipated to Hamper Market Growth.

With enlarging industrialization and modernization people have an unlimited number of choices to pursue a career into. In modern-day society, there are thousands of ways a person earns a living and lead a happy life. As a result, a trend has been witnessed where students opt for other courses but science. Therefore, due to the lack of sufficient skilled professionals in the respective field, the overall growth of the H1N1 vaccine market is anticipated to hinder. Furthermore, around 170 million of the population only took albeit for flu shots in 2021 within the States, more so doing to the heavy lifting COVID-19 vaccination program. Owing to the recent pandemic of COVID-19, people/government has been emphasizing less on providing flu shots. 

H1N1 Vaccine Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the H1N1 Vaccine Market. Key companies in this market are- 

  1. Abbott Laboratories
  2. Pfizer Inc.
  3. AstraZeneca Plc.
  4. GlaxoSmithKline Plc.
  5. Sinovac Biotech
  6. CPL Biologicals
  7. Zydus Cadila
  8. Mitsubishi Tanabe
  9. Seqirus pharmaceutical Company
  10. ID Biomedical Corporation of Quebec 

Recent Developments

  • In December 2021, the outbreak of influenza H1N1 allowed the city of Sao Paula to start vaccination for the swine flu virus. The vaccination became post announcement of receival of around 1 million doses from the Butantan Institute. Furthermore, around 4.5 million people have received a single shot of the H1N1 vaccine. Further, upheaval demand would throughout the year make the demand fluctuate. 
  • In December 2021, A study by a team of European Researchers demonstrated how antibodies generated by influenza A H1N1 strain can help cross-react with the important part of the Sars-Cov-2 spike glycoprotein which interacts with the human cell receptor. Approximately 58–68% of blood donors in Stockholm (Sweden) had detectable antibodies to the tested cross-reactive peptide, NGVEGF, while seasonal influenza vaccination tended to enhance the binding of inhibitory antibodies to SARS-CoV-2. In addition, this peptide has also activated T-cell immunity in 20% of healthy individuals.
  • On June 19, 2021, a few cases of influenza A (H1N1) have been found at a detention center located at the Texas border hemagglutinin belongs to a subclade that may enable viral escape from pre-existing immunity. . The researcher claimed that the aforementioned influenza exhibit properties which are resisting the effects of the antiviral drug “Oseltamivir.” 951 isolated samples were tested within a year from September 2019- to September 2020, of which only four had NA-H275 Y mutation.

Relevant Links: 

Vaccines Market – Forecast (2022 - 2027)

Report Code: HCR 0711

Veterinary Vaccines Market – Forecast (2022 - 2027)

Report Code: HCR 0058

Therapeutic Vaccine Market - Forecast(2022 - 2027)

Report Code: HCR 0397

For more Lifesciences and Healthcare Market reports, please click here

1. H1N1 Vaccine Market Overview
    1.1 Definitions and Scope
2. H1N1 Vaccine Market- Executive Summary
3. H1N1 Vaccine Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. H1N1 Vaccine Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. H1N1 Vaccine Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. H1N1 Vaccine Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. H1N1 Vaccine Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. H1N1 Vaccine Market- By Type (Market Size –$Million/$Billion) 
    8.1 Inactivated
    8.2 Conjugate
    8.3 Attenuated
9. H1N1 Vaccine Market- By Brand (Market Size –$Million/$Billion) 
    9.1 Vaxigrip
    9.2 Nasovac
    9.3 Agripal
    9.4 Influgen
    9.5 Others
10. H1N1 Vaccine Market- By Administration (Market Size –$Million/$Billion) 
    10.1 Subcutaneous
    10.2 Intramuscular
    10.3 Intranasal
    10.4 Intradermal
11.  H1N1 Vaccine Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. H1N1 Vaccine Market - Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs and partnerships
13. H1N1 Vaccine Market – Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. H1N1 Vaccine Market – Key Company List by Country Premium (Premium)
15. H1N1 Vaccine Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"
List of Tables

table 1: H1N1 Vaccine Market Overview 2021-2026
table 2: H1N1 Vaccine Market Leader Analysis 2018-2019 (US$)
table 3: H1N1 Vaccine Market Product Analysis 2018-2019 (US$)
table 4: H1N1 Vaccine Market End User Analysis 2018-2019 (US$)
table 5: H1N1 Vaccine Market Patent Analysis 2013-2018* (US$)
table 6: H1N1 Vaccine Market Financial Analysis 2018-2019 (US$)
table 7: H1N1 Vaccine Market Driver Analysis 2018-2019 (US$)
table 8: H1N1 Vaccine Market Challenges Analysis 2018-2019 (US$)
table 9: H1N1 Vaccine Market Constraint Analysis 2018-2019 (US$)
table 10: H1N1 Vaccine Market Supplier Bargaining Power Analysis 2018-2019 (US$)
table 11: H1N1 Vaccine Market Buyer Bargaining Power Analysis 2018-2019 (US$)
table 12: H1N1 Vaccine Market Threat of Substitutes Analysis 2018-2019 (US$)
table 13: H1N1 Vaccine Market Threat of New Entrants Analysis 2018-2019 (US$)
table 14: H1N1 Vaccine Market Degree of Competition Analysis 2018-2019 (US$)
table 15: H1N1 Vaccine Market Value Chain Analysis 2018-2019 (US$)
table 16: H1N1 Vaccine Market Pricing Analysis 2021-2026 (US$)
table 17: H1N1 Vaccine Market Opportunities Analysis 2021-2026 (US$)
table 18: H1N1 Vaccine Market Product Life Cycle Analysis 2021-2026 (US$)
table 19: H1N1 Vaccine Market Supplier Analysis 2018-2019 (US$)
table 20: H1N1 Vaccine Market Distributor Analysis 2018-2019 (US$)
table 21: H1N1 Vaccine Market Trend Analysis 2018-2019 (US$)
table 22: H1N1 Vaccine Market Size 2018 (US$)
table 23: H1N1 Vaccine Market Forecast Analysis 2021-2026 (US$)
table 24: H1N1 Vaccine Market Sales Forecast Analysis 2021-2026 (Units)
table 25: H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 26: H1N1 Vaccine Market By Type, Revenue & Volume, By Flu shot/ Inactivated Vaccine, 2021-2026 ($)
table 27: H1N1 Vaccine Market By Type, Revenue & Volume, By Nasal Spray/FluMist/Intranasal, 2021-2026 ($)
table 28: H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 29: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Agripal, 2021-2026 ($)
table 30: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Fiuarix, 2021-2026 ($)
table 31: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Influgen, 2021-2026 ($)
table 32: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Influvac, 2021-2026 ($)
table 33: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Nasovac, 2021-2026 ($)
table 34: North America H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 35: North America H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 36: South america H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 37: South america H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 38: Europe H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 39: Europe H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 40: APAC H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 41: APAC H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 42: Middle East & Africa H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 43: Middle East & Africa H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 44: Russia H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 45: Russia H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 46: Israel H1N1 Vaccine Market, Revenue & Volume, By Type, 2021-2026 ($)
table 47: Israel H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2021-2026 ($)
table 48: Top Companies 2018 (US$)H1N1 Vaccine Market, Revenue & Volume
table 49: Product Launch 2018-2019H1N1 Vaccine Market, Revenue & Volume
table 50: Mergers & Acquistions 2018-2019H1N1 Vaccine Market, Revenue & Volume


List of Figures

Figure 1: Overview of H1N1 Vaccine Market 2021-2026
Figure 2: Market Share Analysis for H1N1 Vaccine Market 2018 (US$)
Figure 3: Product Comparison in H1N1 Vaccine Market 2018-2019 (US$)
Figure 4: End User Profile for H1N1 Vaccine Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in H1N1 Vaccine Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in H1N1 Vaccine Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in H1N1 Vaccine Market 2018-2019
Figure 8: Ecosystem Analysis in H1N1 Vaccine Market 2018
Figure 9: Average Selling Price in H1N1 Vaccine Market 2021-2026
Figure 10: Top Opportunites in H1N1 Vaccine Market 2018-2019
Figure 11: Market Life Cycle Analysis in H1N1 Vaccine Market
Figure 12: GlobalBy TypeH1N1 Vaccine Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Type of Brand H1N1 Vaccine Market Revenue, 2021-2026 ($)
Figure 14: Global H1N1 Vaccine Market - By Geography
Figure 15: Global H1N1 Vaccine Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global H1N1 Vaccine Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 18: US H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 60: U.K H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 93: China H1N1 Vaccine Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)H1N1 Vaccine Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa H1N1 Vaccine Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel H1N1 Vaccine Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)H1N1 Vaccine Market
Figure 131: Developments, 2018-2019*H1N1 Vaccine Market
Figure 132: Company 1 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)